-
Amgen Inc. (AMGN)
-
Regeneron Pharmaceuticals Inc. (REGN)
-
Vertex Pharmaceuticals Incorporated (VRTX)
-
Mettler-Toledo International Inc. (MTD)
Q: I'm hearing that pharma and biotech company valuations are at multi year lows. With one chart showing the percentage of US biotechs with market caps below cash value is at a 25 year high, and by a wide margin. Do you feel this sector shows a big opportunity to get good companies for cheap in a sector that will one day improve? If so what companies look best to you in Canada or US? Are there any sectors that are more beaten up? Thx